101 related articles for article (PubMed ID: 23617089)
1. Efficacy and tolerability of fixed-combination acne treatment in adolescents.
Gold LS
Cutis; 2013 Mar; 91(3):152-9. PubMed ID: 23617089
[TBL] [Abstract][Full Text] [Related]
2. Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne in Adult and Pediatric Participants.
Baldwin H; Gold LS; Harper JC; Alexis AF; Callender VD; Kircik L; Guenin E; Eichenfield LF
J Drugs Dermatol; 2024 Jun; 23(6):394-402. PubMed ID: 38834226
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled double-blinded split-face prospective clinical trial to assess the efficacy, safety, and tolerability of a novel 3-step routine compared to benzoyl peroxide for the treatment of mild to moderate acne vulgaris.
Gern A; Walter J; Xu S; Vakharia PP
Arch Dermatol Res; 2024 May; 316(6):230. PubMed ID: 38787441
[TBL] [Abstract][Full Text] [Related]
4. Twelve-week, multicenter, placebo-controlled, randomized, double-blind, parallel-group, comparative phase II/III study of benzoyl peroxide gel in patients with acne vulgaris: A secondary publication.
Kawashima M; Sato S; Furukawa F; Matsunaga K; Akamatsu H; Igarashi A; Tsunemi Y; Hayashi N; Yamamoto Y; Nagare T; Katsuramaki T
J Dermatol; 2017 Jul; 44(7):774-782. PubMed ID: 28295516
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of microencapsulated benzoyl peroxide and microencapsulated tretinoin for the treatment of acne vulgaris: Results from two phase 3 double-blind, randomized, vehicle-controlled studies.
Del Rosso J; Sugarman J; Green L; Lain T; Levy-Hacham O; Mizrahi R; Gold LS
J Am Acad Dermatol; 2023 Oct; 89(4):719-727. PubMed ID: 37356627
[TBL] [Abstract][Full Text] [Related]
6. Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison.
Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Kerrouche N; Tan J
Am J Clin Dermatol; 2018 Apr; 19(2):275-286. PubMed ID: 29549588
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a multitargeted, salicylic acid-based dermocosmetic cream compared to benzoyl peroxide 5% in Acne vulgaris: Results from a randomized study.
Dal Belo SE; Kanoun-Copy L; Lambert C; Cornillon C; Muller B; Jouni H; Moreau M; Palamarchuk I; Kerob D; Aguilar L
J Cosmet Dermatol; 2024 Mar; 23(3):891-897. PubMed ID: 37941097
[TBL] [Abstract][Full Text] [Related]
8. Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel.
Harper JC; Kircik LH; Gold M; Hebert AA; Sugarman JL; Green L; Gold LS; Baldwin H; Guenin E; DelRosso JQ
J Drugs Dermatol; 2024 Mar; 23(3):125-131. PubMed ID: 38443130
[TBL] [Abstract][Full Text] [Related]
9. A Salicylic Acid-Based Dermocosmetic is Effective as an Adjunct to Benzoyl Peroxide for Mild to Moderate Acne and as Monotherapy in Maintenance Post Benzoyl Peroxide.
Khammari A; Demessant-Flavigny A; Kerob D; Seité S; Dréno B
J Drugs Dermatol; 2023 Dec; 22(12):1172-1177. PubMed ID: 38051857
[TBL] [Abstract][Full Text] [Related]
10. Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis.
Kircik LH; Stein Gold L; Gold M; Weiss JS; Harper JC; Del Rosso JQ; Bunick CG; Bhatia N; Tanghetti EA; Eichenfield LF; Baldwin H; Draelos ZD; Callender VD; Han G; Gooderham MJ; Sadick N; Lupo MP; Lain ET; Werschler WP
Dermatol Ther (Heidelb); 2024 May; 14(5):1211-1227. PubMed ID: 38724841
[TBL] [Abstract][Full Text] [Related]
11. Benefit of Topical Combination Therapy for Acne: Analyzing Effect Size Using Number Needed to Treat.
Feldman SR; Han G; Callender VD; Kircik LH; Bhatia N; Tyring SK; Zeichner JA; Gold LS
J Drugs Dermatol; 2024 Feb; 23(2):42-49. PubMed ID: 38306147
[TBL] [Abstract][Full Text] [Related]
12. Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials.
Stein Gold L; Lain E; Del Rosso JQ; Gold M; Draelos ZD; Eichenfield LF; Sadick N; Werschler WP; Gooderham MJ; Lupo M
J Am Acad Dermatol; 2023 Nov; 89(5):927-935. PubMed ID: 37656094
[TBL] [Abstract][Full Text] [Related]
13. A dermocosmetic regimen is able to mitigate skin sensitivity induced by a retinoid-based fixed combination treatment for acne: Results of a randomized clinical trial.
Khammari A; Kerob D; Demessant AL; Nioré M; Dréno B
J Cosmet Dermatol; 2024 Apr; 23(4):1313-1319. PubMed ID: 38102855
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of benzoyl peroxide for acne vulgaris: Comparison between Japanese and Western patients.
Kawashima M; Nagare T; Doi M
J Dermatol; 2017 Nov; 44(11):1212-1218. PubMed ID: 28791735
[TBL] [Abstract][Full Text] [Related]
15. Treatments for Moderate-to-Severe Acne Vulgaris: A Systematic Review and Network Meta-analysis.
Harper JC; Baldwin H; Choudhury SP; Rai D; Ghosh B; Aman MS; Choudhury AR; Dutta SK; Dey D; Bhattacharyya S; Lin T; Joseph G; Dashputre AA; Tan JKL
J Drugs Dermatol; 2024 Apr; 23(4):216-226. PubMed ID: 38564399
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Moderate-to-severe Acne Vulgaris in a Hispanic Population: A
Alexis AF; Cook-Bolden F; Lin T
J Clin Aesthet Dermatol; 2017 Jun; 10(6):36-43. PubMed ID: 28979655
[No Abstract] [Full Text] [Related]
17. From Breakouts to Bargains: Strategies for Patient-Centered, Cost-effective Acne Care.
Shields A; Barbieri JS
Cutis; 2023 Aug; 112(2):E24-E29. PubMed ID: 37820334
[TBL] [Abstract][Full Text] [Related]
18. An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color.
El-Kashlan N; Cices A; Kaufman B; Da Rosa JC; Sanabria-Gonzalez I; Khattri S; Alexis A
J Drugs Dermatol; 2024 Jun; 23(6):410-417. PubMed ID: 38834229
[TBL] [Abstract][Full Text] [Related]
19. Topical Clindamycin in the Management of Acne Vulgaris: Current Perspectives and Recent Therapeutic Advances.
Del Rosso JQ; Bunick CG; Kircik L; Bhatia N
J Drugs Dermatol; 2024 Jun; 23(6):438-445. PubMed ID: 38834223
[TBL] [Abstract][Full Text] [Related]
20. Silica-based microencapsulation used in topical dermatologic applications.
Green LJ; Bhatia ND; Toledano O; Erlich M; Spizuoco A; Goodyear BC; York JP; Jakus J
Arch Dermatol Res; 2023 Dec; 315(10):2787-2793. PubMed ID: 37792034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
